Rest of the world
Outside of Europe and the USA, we continue to support and work towards transparency as industry associations or governments establish specific guidelines for disclosure.
We also continue to work towards publishing global figures at an aggregate level for the payments to HCPs that will continue, for activities such as advisory services and clinical research.
Find out more
We were one of the first pharmaceutical companies in the USA to voluntarily disclose information about our work with physicians
We fully support the EFPIA's Code on the disclosure of individual transfers of value from pharmaceutical companies to healthcare professionals and healthcare organisations
Compassionate use (Expanded access)
Our policy explains our position and criteria for assessing requests and provides a link for health care professionals’ requests.
We are changing the way we work to further embed our values in everything we do, including the way we research, develop, sell and market our products